Newsroom
Category
May 25, 2023
While it won’t cure children of type 1 diabetes, the “bionic pancreas,” an artificial intelligence-powered system cleared Friday, May 19, by the U.S. Food and Drug Administration, will relieve youth and their parents of constant worries over estimating insulin doses and carb intake from food.
May 23, 2023
An improvement in 6-month progression-free survival warrants additional study in a larger trial, researchers said. The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM). The Mays Cancer Center, one of the four National Cancer […]
May 18, 2023
UT Health San Antonio President William L. Henrich, MD, MACP, was quoted in this article. Read Now
May 17, 2023
Glioblastoma-impacted mice lived longer when treated with combination of molecule drug and chemotherapy agent Glioblastoma (GBM), a highly devastating brain tumor, has long posed challenges as effective treatments have remained elusive. Despite responding initially to treatment, GBM patients often experience therapy resistance leading to low long-term survival rates, with only 7.2% of patients surviving beyond […]
May 2, 2023
$100 million comprehensive research and patient care center will offer the latest advancing therapies for dementia and all neurologic disorders Amid a rising tsunami of needed care for dementia and other neurologic diseases, construction began this week on the $100 million Center for Brain Health, a new patient care and clinical trials facility of The […]
May 1, 2023
This spring, UT Health San Antonio announced it will build a $100 million Center for Brain Health to enhance its Biggs Institute and the Department of Neurology of its Joe R. and Teresa Lozano Long School of Medicine.
